Could a common liver pill speed up jaundice recovery in newborns?

NCT ID NCT07110987

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether adding a medicine called ursodeoxycholic acid (UDCA) to standard light therapy helps clear jaundice faster in newborns. About 70 babies born at 34 weeks or later with jaundice will be randomly assigned to receive either light therapy alone or light therapy plus UDCA. The goal is to see if UDCA reduces the time needed for treatment and shortens hospital stays.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HYPERBILIRUBINEMIA, NEONATAL INDIRECT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

G6PD deficiency hyperbilirubinemia Hyperbilirubinemia, Neonatal transient familial neonatal hyperbilirubinemia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Lattakia University Hospital

    RECRUITING

    Latakia, 0000, Syria

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact